Why is There a Mad Dash to Manufacture Effective Drugs to Combat the COVID-19 Coronavirus?

Because it’s more lucrative to manage symptoms.

Photo by freestocks on Unsplash

Let’s face it. It’s a sad day when you realise that Big Pharma is in a race to produce pharmaceuticals that can provide help in managing the symptoms of the COVID-19 coronavirus better.

--

--

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store
Dr Joel Yong, PhD

Dr Joel Yong, PhD

2.7K Followers

Crafting strategies for optimising the biochemical pathways in the human body. Learn more at https://thethinkingscientist.substack.com.